|
1
|
Heller DA, de Faire U, Pedersen NL, Dahlén
G and McClearn GE: Genetic and environmental influences on serum
lipid levels in twins. N Engl J Med. 328:1150–1156. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ordovas JM: Nutrigenetics, plasma lipids,
and cardiovascular risk. J Am Diet Assoc. 106:1074–1081. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Go AS, Mozaffarian D, Roger VL, et al:
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics - 2014
update: A report from the American Heart Association. Circulation.
129. pp. e28–e292. 2014, View Article : Google Scholar
|
|
4
|
Takamatsu N, Abe H, Tominaga T, Nakahara
K, Ito Y, Okumoto Y, Kim J, Kitakaze M and Doi T: Risk factors for
chronic kidney disease in Japan: A community-based study. BMC
Nephrol. 10:342009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Willer CJ, Schmidt EM, Sengupta S, et al:
Global Lipids Genetics Consortium: Discovery and refinement of loci
associated with lipid levels. Nat Genet. 45:1274–1283. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teslovich TM, Musunuru K, Smith AV, et al:
Biological, clinical and population relevance of 95 loci for blood
lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aulchenko YS, Ripatti S, Lindqvist I, et
al: ENGAGE Consortium: Loci influencing lipid levels and coronary
heart disease risk in 16 European population cohorts. Nat Genet.
41:47–55. 2009. View
Article : Google Scholar :
|
|
8
|
Kathiresan S, Willer CJ, Peloso GM, et al:
Common variants at 30 loci contribute to polygenic dyslipidemia.
Nat Genet. 41:56–65. 2009. View
Article : Google Scholar
|
|
9
|
Kathiresan S, Melander O, Guiducci C, et
al: Six new loci associated with blood low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol or triglycerides
in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamada Y, Matsuo H, Warita S, et al:
Prediction of genetic risk for dyslipidemia. Genomics. 90:551–558.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamada Y, Kato K, Hibino T, et al:
Prediction of genetic risk for metabolic syndrome. Atherosclerosis.
191:298–304. 2007. View Article : Google Scholar
|
|
12
|
Yamada Y, Ichihara S, Kato K, et al:
Genetic risk for metabolic syndrome: Examination of candidate gene
polymorphisms related to lipid metabolism in Japanese people. J Med
Genet. 45:22–28. 2008. View Article : Google Scholar
|
|
13
|
James MT, Hemmelgarn BR and Tonelli M:
Early recognition and prevention of chronic kidney disease. Lancet.
375:1296–1309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weiner DE, Tighiouart H, Amin MG, Stark
PC, MacLeod B, Griffith JL, Salem DN, Levey AS and Sarnak MJ:
Chronic kidney disease as a risk factor for cardiovascular disease
and all-cause mortality: A pooled analysis of community-based
studies. J Am Soc Nephrol. 15:1307–1315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsushita K, van der Velde M, Astor BC,
Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Chronic
Kidney and Disease Prognosis: Consortium: Association of estimated
glomerular filtration rate and albuminuria with all-cause and
cardiovascular mortality in general population cohorts: A
collaborative meta-analysis. Lancet. 375:2073–2081. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
National Kidney Foundation: K/DOQI
clinical practice guidelines for chronic kidney disease:
Evaluation, classification, and stratification. Am J Kidney Dis.
39(Suppl 1): S1–S266. 2002.PubMed/NCBI
|
|
17
|
Yamagata K, Ishida K, Sairenchi T,
Takahashi H, Ohba S, Shiigai T, Narita M and Koyama A: Risk factors
for chronic kidney disease in a community-based population: A
10-year follow-up study. Kidney Int. 71:159–166. 2007. View Article : Google Scholar
|
|
18
|
Friedman DJ and Pollak MR: Genetics of
kidney failure and the evolving story of APOL1. J Clin Invest.
121:3367–3374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Köttgen A, Glazer NL, Dehghan A, et al:
Multiple loci associated with indices of renal function and chronic
kidney disease. Nat Genet. 41:712–717. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chambers JC, Zhang W, Lord GM, et al:
Genetic loci influencing kidney function and chronic kidney
disease. Nat Genet. 42:373–375. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Köttgen A, Pattaro C, Böger CA, et al: New
loci associated with kidney function and chronic kidney disease.
Nat Genet. 42:376–384. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Böger CA, Gorski M, Li M, et al: CKDGen
Consortium: Association of eGFR-related loci identified by GWAS
with incident CKD and ESRD. PLoS Genet. 7:e10022922011. View Article : Google Scholar
|
|
23
|
Pattaro C, Köttgen A, Teumer A, et al:
CARDIoGRAM Consortium; ICBP Consortium; CARe Consortium; Wellcome
Trust Case Control Consortium 2 (WTCCC2): Genome-wide association
and functional follow-up reveals new loci for kidney function. PLoS
Genet. 8:e10025842012. View Article : Google Scholar
|
|
24
|
Kao WH, Klag MJ, Meoni LA, et al: Family
Investigation of Nephropathy and Diabetes Research Group: MYH9 is
associated with nondiabetic end-stage renal disease in African
Americans. Nat Genet. 40:1185–1192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu CT, Garnaas MK, Tin A, et al: CKDGen
Consortium: Genetic association for renal traits among participants
of African ancestry reveals new loci for renal function. PLoS
Genet. 7:e10022642011. View Article : Google Scholar
|
|
26
|
Okada Y, Sim X, Go MJ, et al: KidneyGen
Consortium; CKDGen Consortium; GUGC consortium: Meta-analysis
identifies multiple loci associated with kidney function-related
traits in east Asian populations. Nat Genet. 44:904–909. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada Y, Nishida T, Ichihara S, et al:
Association of a polymorphism of BTN2A1 with myocardial infarction
in East Asian populations. Atherosclerosis. 215:145–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamada Y, Fuku N, Tanaka M, et al:
Identification of CELSR1 as a susceptibility gene for ischemic
stroke in Japanese individuals by a genome-wide association study.
Atherosclerosis. 207:144–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamada Y, Nishida T, Ichihara S, et al:
Identification of chromosome 3q28 and ALPK1 as susceptibility loci
for chronic kidney disease in Japanese individuals by a genome-wide
association study. J Med Genet. 50:410–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamada Y, Matsuo H, Segawa T, et al:
Assessment of genetic risk for myocardial infarction. Thromb
Haemost. 96:220–227. 2006.PubMed/NCBI
|
|
31
|
Fujimaki T, Kato K, Yoshida T, et al:
Association of genetic variants with myocardial infarction in
Japanese individuals with chronic kidney disease. Thromb Haemost.
101:963–968. 2009.PubMed/NCBI
|
|
32
|
Oguri M, Kato K, Yokoi K, et al:
Association of genetic variants with myocardial infarction in
Japanese individuals with metabolic syndrome. Atherosclerosis.
206:486–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamada Y, Matsui K, Takeuchi I, Oguri M
and Fujimaki T: Association of genetic variants with hypertension
in a longitudinal population-based genetic epidemiological study.
Int J Mol Med. 35:1189–1198. 2015.
|
|
34
|
Shimokata S, Oguri M, Fujimaki T, Horibe
H, Kato K and Yamada Y: Association between polymorphisms of the
α-kinase 1 gene and type 2 diabetes mellitus in community-dwelling
individuals. Biomed Rep. 1:940–944. 2013.
|
|
35
|
Ueyama C, Horibe H, Fujimaki T, Oguri M,
Kato K and Yamada Y: Association of genetic variants of CELSR1 and
3q28 with hypertension in community-dwelling individuals. Biomed
Rep. 1:840–844. 2013.
|
|
36
|
Oguri M, Fujimaki T, Horibe H, Kato K,
Ichihara S and Yamada Y: Association of a polymorphism of BTN2A1
with chronic kidney disease in community-dwelling individuals.
Biomed Rep. 1:868–872. 2013.
|
|
37
|
Fujimaki T, Horibe H, Oguri M, Kato K and
Yamada Y: Association of genetic variants of the α-kinase 1 gene
with myocardial infarction in community-dwelling individuals.
Biomed Rep. 2:127–131. 2014.PubMed/NCBI
|
|
38
|
Horibe H, Ueyama C, Fujimaki T, Oguri M,
Kato K, Ichihara S and Yamada Y: Association of a polymorphism of
BTN2A1 with dyslipidemia in community-dwelling individuals. Mol Med
Rep. 9:808–812. 2014.PubMed/NCBI
|
|
39
|
Murakata Y, Fujimaki T and Yamada Y:
Association of a butyrophilin, subfamily 2, member A1 gene
polymorphism with hypertension. Biomed Rep. 2:818–822.
2014.PubMed/NCBI
|
|
40
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A;
Collaborators developing the Japanese equation for estimated GFR:
Revised equations for estimated GFR from serum creatinine in Japan.
Am J Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Itoh Y, Mizuki N, Shimada T, Azuma F,
Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M and Inoko H:
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gibbons RD, Hedeker D and DuToit S:
Advances in analysis of longitudinal data. Annu Rev Clin Psychol.
6:79–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng J, Edwards LJ, Maldonado-Molina MM,
Komro KA and Muller KE: Real longitudinal data analysis for real
people: Building a good enough mixed model. Stat Med. 29:504–520.
2010.
|
|
44
|
Fujimaki T, Kato K, Oguri M, et al:
Association of a polymorphism of BTN2A1 with dyslipidemia in East
Asian populations. Exp Ther Med. 2:745–749. 2011.PubMed/NCBI
|
|
45
|
Yoshida T, Kato K, Horibe H, Oguri M,
Fukuda M, Satoh K, Aoyagi Y, Shinkai S, Nozawa Y and Yamada Y:
Association of a genetic variant of BTN2A1 with chronic kidney
disease in Japanese individuals. Nephrology (Carlton). 16:642–648.
2011.
|
|
46
|
Arnett HA, Escobar SS and Viney JL:
Regulation of costimulation in the era of butyrophilins. Cytokine.
46:370–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Oguri M, Kato K, Yoshida T, et al:
Association of a genetic variant of BTN2A1 with metabolic syndrome
in East Asian populations. J Med Genet. 48:787–792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Khovidhunkit W, Kim MS, Memon RA,
Shigenaga JK, Moser AH, Feingold KR and Grunfeld C: Effects of
infection and inflammation on lipid and lipoprotein metabolism:
Mechanisms and consequences to the host. J Lipid Res. 45:1169–1196.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Esteve E, Ricart W and Fernández-Real JM:
Dyslipidemia and inflammation: An evolutionary conserved mechanism.
Clin Nutr. 24:16–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McGillicuddy FC, de la Llera Moya M,
Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH and
Reilly MP: Inflammation impairs reverse cholesterol transport in
vivo. Circulation. 119:1135–1145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Reiss AB: Effects of inflammation on
cholesterol metabolism: Impact on systemic lupus erythematosus.
Curr Rheumatol Rep. 11:255–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kawakami T, Mimura I, Shoji K, Tanaka T
and Nangaku M: Hypoxia and fibrosis in chronic kidney disease:
Crossing at pericytes. Kidney Int Suppl. 2011.4:107–112. 2014.
View Article : Google Scholar
|
|
53
|
Schnaper HW and Kopp JB: Why kidneys fail:
Report from an American Society of Nephrology Advances in Research
Conference. J Am Soc Nephrol. 17:1777–1781. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ricardo SD, van Goor H and Eddy AA:
Macrophage diversity in renal injury and repair. J Clin Invest.
118:3522–3530. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Brosius FC III: New insights into the
mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev
Endocr Metab Disord. 9:245–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shim J, Lim H, R Yates J and Karin M:
Nuclear export of NF90 is required for interleukin-2 mRNA
stabilization. Mol Cell. 10:1331–1344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu Q, Lu YY, Noh H, Hong S, Dong Z, Ding
HF, Su SB and Huang S: Interleukin enhancer-binding factor 3
promotes breast tumor progression by regulating sustained
urokinase-type plasminogen activator expression. Oncogene.
32:3933–3943. 2013. View Article : Google Scholar
|
|
58
|
Wang SJ, Tu HP, Ko AM, Chiang SL, Chiou
SJ, Lee SS, Tsai YS, Lee CP and Ko YC: Lymphocyte α-kinase is a
gout-susceptible gene involved in monosodium urate
monohydrate-induced inflammatory responses. J Mol Med (Berl).
89:1241–1251. 2011. View Article : Google Scholar
|
